Exhibit 99.1

| | | | |
Media Contact | | | | Investor Relations |
Melissa Woods | | | | Jessica Bartlow |
T+ 1.405.269.9453 | | | | T+ 1.703.678.2114 |
melissa.woods@icxt.com | | | | jessica.bartlow@icxt.com |
ICx Technologies Reports Third-Quarter 2009 Results
Records Fifth Consecutive Profitable Quarter
Arlington, Va. (Nov. 12, 2009) – ICx Technologies, Inc. (Nasdaq GS: ICXT), a developer of advanced sensor technologies for homeland security, force protection and commercial applications, announced today its operating and financial results for the third quarter ended September 30, 2009.
Third-Quarter and Nine Month Financials
For the quarter ended September 30, 2009, ICx reported revenues of $42.8 million, compared to $44.3 million for the quarter ended September 30, 2008, representing a 3.4 percent decrease year-over-year. The company achieved its fifth consecutive positive quarter, showing adjusted EBITDA profits of $2.3 million, an improvement of $1.3 million over the third-quarter adjusted EBITDA profits in 2008. Funded backlog held strong at $78 million at the end of the third-quarter, up from $73 million reported in the second quarter. For the nine months ended September 30, 2009, the Company’s revenue grew by 15 percent to $135 million, compared to $117 million for the nine months ended September 30, 2008. Adjusted EBITDA for the first nine months of 2009 was $6 million compared to an adjusted EBITDA loss of ($9.2) million for the same period last year.
With continued positive adjusted EBITDA over five quarters, the Company has good growth year-to-date and solid potential for the fourth-quarter despite lower than expected revenue for the third-quarter.
“Although contracting delays and revenue recognition delays resulted in third-quarter revenues that were lower than expected, we are pleased with our year to date growth,” said Colin Cumming, CEO of ICx Technologies. “With our fifth consecutive positive adjusted EBITDA quarter, we are confident in our long term growth strategy in a difficult economic climate.”
Key Third-Quarter Highlights
| • | | Awarded a key Detect-to-Protect Contract for Mass Transit Security |
| • | | A pilot program to rapidly detect and identify the potential release of bio-threat agents |
| • | | The Joint Force Protection Advanced Security System (JFPASS) program achieved a significant milestone with positive tests during the recent test and evaluation at a major US military installation |
| • | | Awarded a $3.6 million Mass Spectrometer Contract for the Pentagon Force Protection Agency (PFPA) |
| • | | A key deployment for our ThreatSense facility protection technologies |
| • | | ICx Helped Secure Water Quality During the G-20 Summit in Pittsburgh, PA |
| • | | A DHS designated National Special Security Event |
Revenue and Earnings Outlook for 2009
The Company is reconfirming its earlier annual Adjusted EBITDA guidance of $5 million to $8 million. Based on the delay in the DoD budget process, as well as possible delays in certain international sales and discontinued operations, the Company is revising its annual revenue guidance for the year ending December 31, 2009, to a range of $180 million to $190 million.
Conference Call
In connection with the earnings release, ICx will host a conference call and Webcast for investors and analysts to discuss its results for the quarter on November 12, 2009, at 4:30 Eastern time.
Participants should call, toll-free, 1.888.205.6458 (United States/Canada), or 1.913.312.1408, and request the ICx Technologies call. A telephonic replay will be available for anyone unable to participate in the live call. To access the replay, call 1.719.457.0820 (United States/Canada), or call toll-free at 1.888.203.1112 and enter confirmation code 9199542. The recording will be available from 7:30 p.m. (EST) on Thursday, Nov. 12, 2009, through midnight, Nov. 26, 2009 (EST). A live broadcast of the earnings conference call will also be available via the Internet at http://www.ICXT.com in the ‘Events & Presentations’ section under ‘Investor Relations’. The webcast will be archived on the site for 60 days.
About ICx Technologies, Inc.
ICx Technologies is a leader in the development and integration of advanced sensor technologies for homeland security, force protection and commercial applications. Our proprietary sensors detect and identify chemical, biological, radiological, nuclear and explosive threats, and deliver superior awareness and actionable intelligence for wide-area surveillance, intrusion detection and facility security. We then leverage our unparalleled technical expertise and government funding to address other emerging challenges of our time, ranging from a cleaner environment and alternative energy to life science.
Safe-Harbor Statement
All forward-looking statements contained in this release are made within the meaning of and pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are all statements other than statements of historical facts, including but not limited to statements concerning the outlook for the Company’s revenues and Adjusted EBITDA for fiscal 2009; and all other statements concerning the plans, intentions, expectations, projections, hopes, beliefs, objectives, goals and strategies of management. Forward-looking statements are not guarantees of future performance or events and are subject to a number of known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed, projected or implied by such forward-looking statements. Important risks, uncertainties and other factors include, but are not limited to, demand for the Company’s products and services; the ability of the Company to successfully develop and expand its products, services, technologies and markets; the ability of the Company to effectively assimilate acquired businesses and achieve the anticipated benefits of its acquisitions; changes in U.S. government funding levels to purchase the Company’s products and services; the ability of the Company to sell its products to original equipment manufacturers, prime contractors and system integrators; seasonality; competition; the ability of the Company to develop innovative products; the ability of the Company to attract, retain and motivate key personnel; the ability of the Company to secure and maintain key contracts and relationships, including contracts with the U.S. government; general economic, market and business conditions, uncertainties and other factors identified from time to time in the Company’s filings with the Securities and Exchange Commission. Accordingly, there can be no assurance that the results expressed, projected or implied by any forward-looking statements will be achieved, and readers are cautioned not to place undue reliance on any forward-looking statements. The forward-looking statements in this press release speak only as of the date hereof and are based on the current plans, goals, objectives, strategies, intentions, expectations and assumptions of, and the information currently available to, management. The Company assumes no duty or obligation to update or revise any forward-looking statements for any reason, whether as the result of changes in expectations, new information, future events, conditions or circumstances or otherwise.
Use of Non-GAAP Financial Measures
In evaluating its business, ICx considers and uses Adjusted EBITDA as a supplemental measure of its operating performance. The Company defines Adjusted EBITDA as earnings from continuing operations before interest, taxes, depreciation and amortization, plus non-cash equity compensation. The Company also presents Adjusted EBITDA because it believes it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance. The term Adjusted EBITDA is not defined under U.S. generally accepted accounting principles, or U.S. GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with U.S. GAAP. Adjusted EBITDA has limitations as an analytical tool, and when assessing the Company’s operating performance, investors should not consider Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with U.S. GAAP. Among other things, Adjusted EBITDA does not reflect the Company’s actual cash expenditures. Other companies may calculate similar measures differently than ICx, limiting their usefulness as comparative tools. ICx compensates for these limitations by relying primarily on its GAAP results and using Adjusted EBITDA only supplementally.
ICx TECHNOLOGIES, INC. AND SUBSIDIARIES
Consolidated Statements of Operations and Net Loss
(Unaudited)
(dollars in thousands, except per share amounts)
| | | | | | | | | | | | | | | | |
| | Unaudited | | | Unaudited | |
| | Three Months Ended September 30, | | | Nine Months Ended September 30, | |
| | 2009 | | | 2008 | | | 2009 | | | 2008 | |
Revenues: | | | | | | | | | | | | | | | | |
Product revenues | | $ | 19,966 | | | $ | 24,982 | | | $ | 58,410 | | | $ | 68,546 | |
Contract research and development revenues | | | 15,066 | | | | 8,854 | | | | 39,041 | | | | 30,652 | |
Service and other revenue | | | 7,788 | | | | 10,502 | | | | 37,750 | | | | 18,305 | |
| | | | | | | | | | | | | | | | |
Total revenues | | | 42,820 | | | | 44,338 | | | | 135,201 | | | | 117,503 | |
| | | | | | | | | | | | | | | | |
| | | | |
Cost of revenues: | | | | | | | | | | | | | | | | |
Cost of product revenues | | | 9,047 | | | | 11,756 | | | | 27,984 | | | | 32,842 | |
Cost of contract research and development revenues | | | 10,445 | | | | 5,909 | | | | 28,325 | | | | 20,398 | |
Cost of service and other revenues | | | 5,758 | | | | 6,919 | | | | 27,289 | | | | 11,771 | |
| | | | | | | | | | | | | | | | |
Total cost of revenue | | | 25,250 | | | | 24,584 | | | | 83,598 | | | | 65,011 | |
| | | | | | | | | | | | | | | | |
Gross profit | | | 17,570 | | | | 19,754 | | | | 51,603 | | | | 52,492 | |
| | | | | | | | | | | | | | | | |
| | | | |
Operating expenses: | | | | | | | | | | | | | | | | |
General and administrative | | | 6,450 | | | | 7,585 | | | | 20,357 | | | | 24,938 | |
Sales and marketing | | | 5,354 | | | | 7,135 | | | | 17,549 | | | | 23,083 | |
Research and development | | | 4,203 | | | | 5,494 | | | | 10,823 | | | | 17,865 | |
Depreciation and amortization | | | 2,664 | | | | 3,461 | | | | 8,683 | | | | 9,822 | |
| | | | | | | | | | | | | | | | |
Total operating expenses | | | 18,671 | | | | 23,675 | | | | 57,412 | | | | 75,708 | |
| | | | | | | | | | | | | | | | |
Operating loss | | | (1,101 | ) | | | (3,921 | ) | | | (5,809 | ) | | | (23,216 | ) |
| | | | | | | | | | | | | | | | |
| | | | |
Other income (expense): | | | | | | | | | | | | | | | | |
Interest income | | | 36 | | | | 191 | | | | 127 | | | | 867 | |
Interest expense | | | (24 | ) | | | (20 | ) | | | (78 | ) | | | (49 | ) |
Other, net | | | (276 | ) | | | 114 | | | | 125 | | | | (265 | ) |
| | | | | | | | | | | | | | | | |
Total other income (expense) | | | (264 | ) | | | 285 | | | | 174 | | | | 553 | |
| | | | | | | | | | | | | | | | |
Loss before income taxes | | | (1,365 | ) | | | (3,636 | ) | | | (5,635 | ) | | | (22,663 | ) |
Income tax expense (benefit) | | | (36 | ) | | | (125 | ) | | | 200 | | | | 75 | |
| | | | | | | | | | | | | | | | |
Loss from continuing operations | | $ | (1,329 | ) | | $ | (3,511 | ) | | $ | (5,835 | ) | | $ | (22,738 | ) |
Loss on discontinued operations, net of tax | | | (2,528 | ) | | | (306 | ) | | | (2,768 | ) | | | (1,271 | ) |
Loss on sale of discontinued operations, net of tax | | | — | | | | — | | | | — | | | | (903 | ) |
| | | | | | | | | | | | | | | | |
Net loss | | $ | (3,857 | ) | | $ | (3,817 | ) | | $ | (8,603 | ) | | $ | (24,912 | ) |
| | | | | | | | | | | | | | | | |
| | | | |
Other comprehensive income | | | | | | | | | | | | | | | | |
Foreign currency translation adjustment, net of tax | | | 797 | | | | (1,082 | ) | | | (117 | ) | | | (361 | ) |
| | | | | | | | | | | | | | | | |
Comprehensive loss | | $ | (3,060 | ) | | $ | (4,899 | ) | | $ | (8,720 | ) | | $ | (25,273 | ) |
| | | | | | | | | | | | | | | | |
| | | | |
Net loss per common share | | | | | | | | | | | | | | | | |
Basic and diluted | | $ | (0.11 | ) | | $ | (0.11 | ) | | $ | (0.25 | ) | | $ | (0.73 | ) |
| | | | | | | | | | | | | | | | |
| | | | |
Reconciliation of Non-GAAP Measure: | | | | | | | | | | | | | | | | |
Net loss | | $ | (3,857 | ) | | $ | (3,817 | ) | | $ | (8,603 | ) | | $ | (24,912 | ) |
Add (subtract) | | | | | | | | | | | | | | | | |
Loss from discontinued operations | | | 2,528 | | | | 306 | | | | 2,768 | | | | 2,174 | |
Income tax expense (benefit) | | | (36 | ) | | | (125 | ) | | | 200 | | | | 75 | |
Interest income | | | (36 | ) | | | (191 | ) | | | (127 | ) | | | (867 | ) |
Interest expense | | | 24 | | | | 20 | | | | 78 | | | | 49 | |
Depreciation and amortization | | | 2,664 | | | | 3,461 | | | | 8,683 | | | | 9,822 | |
Stock-based compensation expense | | | 979 | | | | 1,351 | | | | 2,964 | | | | 4,451 | |
| | | | | | | | | | | | | | | | |
Adjusted EBITDA | | $ | 2,266 | | | $ | 1,005 | | | $ | 5,963 | | | $ | (9,208 | ) |
| | | | | | | | | | | | | | | | |
ICx TECHNOLOGIES, INC. AND SUBSIDIARIES
Condensed Balance Sheets
(Unaudited)
(dollars in thousands)
| | | | | | |
| | September 30, 2009 | | December 31, 2008 |
Assets | | | | | | |
Current assets: | | | | | | |
Cash and cash equivalents | | $ | 22,669 | | $ | 30,354 |
Restricted cash | | | 8,456 | | | 8,428 |
Trade accounts receivable, net | | | 31,675 | | | 36,547 |
Unbilled revenue | | | 10,314 | | | 10,997 |
Inventories | | | 24,007 | | | 26,174 |
Other current assets | | | 5,916 | | | 2,651 |
Current assets of discontinued operations | | | 241 | | | 619 |
| | | | | | |
Total current assets | | | 103,278 | | | 115,770 |
Property, plant and equipment, net | | | 10,517 | | | 10,850 |
Goodwill and intangibles, net | | | 81,681 | | | 87,575 |
Other noncurrent assets | | | 3,175 | | | 2,344 |
Noncurrent assets of discontinued operations | | | 378 | | | 2,759 |
| | | | | | |
Total assets | | $ | 199,029 | | $ | 219,298 |
| | | | | | |
| | |
Liabilities and Stockholders’ Equity | | | | | | |
| | |
Current liabilities | | $ | 25,740 | | $ | 38,828 |
Current liabilities of discontinued operations | | | 118 | | | 198 |
Noncurrent liabilities | | | 1,486 | | | 2,465 |
| | | | | | |
Total liabilities | | | 27,344 | | | 41,491 |
| | | | | | |
| | |
Total stockholders’ equity | | | 171,685 | | | 177,807 |
| | | | | | |
Total liabilities and stockholders’ equity | | $ | 199,029 | | $ | 219,298 |
| | | | | | |
ICx TECHNOLOGIES, INC. AND SUBSIDIARIES
Selected Segment Information
(Unaudited)
(dollars in thousands)
| | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Nine Months Ended September 30, | |
| | 2009 | | | 2008 | | | 2009 | | | 2008 | |
Detection | | | | | | | | | | | | | | | | |
Product revenue | | $ | 10,800 | | | $ | 16,716 | | | $ | 30,981 | | | $ | 43,277 | |
Contract research and development revenue | | | 14,594 | | | | 8,070 | | | | 38,252 | | | | 24,143 | |
Service and other revenue | | | 795 | | | | 633 | | | | 2,477 | | | | 1,429 | |
| | | | | | | | | | | | | | | | |
Total revenue | | $ | 26,189 | | | $ | 25,419 | | | $ | 71,710 | | | $ | 68,849 | |
Gross profit % | | | 41.5 | % | | | 51.5 | % | | | 40.7 | % | | | 49.8 | % |
| | | | | | | | | | | | | | | | |
| | | | |
Surveillance | | | | | | | | | | | | | | | | |
Product revenue | | $ | 7,111 | | | $ | 6,523 | | | $ | 21,638 | | | $ | 19,221 | |
Contract research and development revenue | | | 472 | | | | 612 | | | | 789 | | | | 6,303 | |
Service and other revenue | | | 1,662 | | | | 5,536 | | | | 16,287 | | | | 6,392 | |
| | | | | | | | | | | | | | | | |
Total revenue(1) | | $ | 9,245 | | | $ | 12,671 | | | $ | 38,714 | | | $ | 31,916 | |
Gross profit % | | | 43.4 | % | | | 34.5 | % | | | 36.4 | % | | | 37.4 | % |
| | | | | | | | | | | | | | | | |
| | | | |
Solutions | | | | | | | | | | | | | | | | |
Product revenue | | $ | 2,144 | | | $ | 1,743 | | | $ | 5,912 | | | $ | 6,047 | |
Contract research and development revenue | | | 63 | | | | 172 | | | | 219 | | | | 206 | |
Service and other revenue | | | 5,537 | | | | 4,333 | | | | 19,453 | | | | 10,484 | |
| | | | | | | | | | | | | | | | |
Total revenue(2) | | $ | 7,744 | | | $ | 6,248 | | | $ | 25,584 | | | $ | 16,737 | |
Gross profit % | | | 34.7 | % | | | 36.6 | % | | | 32.6 | % | | | 37.7 | % |
| | | | | | | | | | | | | | | | |
(1) | Includes $64 and $72 of intersegment revenue that has been eliminated in the Consolidated Statement of Operations and Net Loss for the three and nine months ended September 30, 2009, respectively |
(2) | Includes $294 and $735 of intersegment revenue that has been eliminated in the Consolidated Statement of Operations and Net Loss for the three and nine months ended September 30, 2009, respectively |